Business Standard

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Sohini Das Mumbai
At least four coronavirus vaccine candidates globally – Oxford-AstraZeneca viral vector vaccine, Moderna's mRNA vaccine, Pfizer-BionTech's mRNA vaccine and Novavax's protein sub-unit vaccine – are expected to receive approvals by the end of 2020 or early 2021. So, India should finally get an approved Covid-19 vaccine by the first quarter of 2021, say analysts.
 
The country has access to two of the four mentioned above – the Oxford-AstraZeneca and Novavax ones – through partnerships. While the Novavax candidate has so far shown a higher level of antibodies and viral neutralisation, both claim good T-cell response (immune response). It also

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 28 2020 | 2:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com